RecruitingPhase 3NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Sponsor: Sanofi
Phoenix, AZ · +20 more sites
6 recruiting sickle cell disease studies with a site in Phoenix, AZ.
Sponsor: Sanofi
Phoenix, AZ · +20 more sites
Sponsor: Novo Nordisk A/S
Phoenix, AZ · +38 more sites
Sponsor: Novo Nordisk A/S
Phoenix, AZ · +49 more sites
Sponsor: American Thrombosis and Hemostasis Network
Phoenix, AZ · +75 more sites
Sponsor: Beam Therapeutics Inc.
Phoenix, AZ · +16 more sites
Sponsor: RTI International
Phoenix, AZ · +8 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.